Key findings suggest that finding solution space among country, industry and donors for pneumococcal vaccine introduction is indeed feasible, although not without challenges.

Finding solution space among country, industry and donors for pneumococcal vaccine introduction is feasible, but not without challenges

PneumoADIP Web-Based Survey 2005

View additional news from the field>>

Key Findings

Summer, 2005. PneumoADIP conducted a web-based survey during the summer in order to assess what the broad pneumococcal community thinks about childhood pneumococcal vaccine supply and financing. 90 respondents self-identified themselves as researchers, clinicians, working in industry, in technical agencies, in NGOs, or in other areas. Once again, thank you to the individuals who participated in this anonymous survey; your inputs are valuable in moving forward.

Key findings suggest that finding solution space among country, industry and donors for pneumococcal vaccine introduction is indeed feasible, although not without challenges.

  • 71% responded that multi-valent pneumococcal conjugate vaccines can be made affordable to developing countries
  • 70% responded that the cost of manufacturing multi-valent vaccines is higher than the willingness to pay
  • 77% responded that researchers can influence donors and policy makers in decisions about pneumococcal vaccine introduction
  • 74% responded that companies should make a profit on vaccines that are supplied to developing countries

View additional news from the field>>